Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metsä Board’s comparable operating result in January–September 2019 was EUR 145 million

Metsä Board Corporation Interim Report 1 January–30 September 2019 31 October 2019 at 12:00 noon EETJanuary–September 2019 (1–9/2018) • Sales were EUR 1,453.4 million (1,486.1). • Comparable operating result was EUR 145.3 million (191.9), or 10.0% (12.9%) of sales. Operating result was EUR 160.8 million (186.3). • Comparable earnings per share were EUR 0.32 (0.44), and earnings per share were EUR 0.36 (0.43). • Comparable return on capital employed was 11.0% (14.7%). July–September 2019 (4–6/2019) • Sales were EUR 489.2 million (477.1). • Comparable operating result was

Nokian Tyres chooses iLOQ S10 digital locking system for the up coming testing center in Spain

Nokian Tyres’ new testing center in Spain enables year-round testing of summer, all-season and winter tires and the tracks will be ready in 2020. The total investment is estimated to be EUR 60 million. For the digital locking system, Nokian Tyres has chosen to partner with iLOQ. iLOQ is a Finnish company whose innovative technology and software is used to create self-powered digital locking and mobile access management solutions. With a focus on enhancing safety while reducing costs and conserving natural resources, in 2019 alone, iLOQ’s solutions will eliminate 27,000 kg of

Realfiction announces the positive outcome of a novelty search regarding the patent pending ECHO technology

The Danish Patent and Trademark Office and Budde Schou, Patent Attorneys have carried out novelty searches as part of the patentability investigation of the invention behind the ECHO technology and conclude that Realfiction’s directional pixel technology is novel with respect to the known techniques identified by the Danish Patent and Trademark Office Examiner and presents distinct advantages.It is common practice that the European patent authorities carry out a patentability investigation through research into existing technology that culminates in a written opinion regarding the

OmniCar Holding AB: Claus T. Hansen CEO of Omnicar Holding increase his share holdings with 200.000 shares

Claus T. Hansen CEO of Omnicar Holding AB have acquired 200.000 shares in Omnicar Holding AB on the 30th October 2019 Claus T. Hansen says “as previous annonced on 19th of September 2019 I am currently increasing my holdings. My total purchase of shares during Q3 are now 400.000 shares. I expect to increase my shareholding further during Q4.  For more information about OmniCar Holding AB, please contact: Claus T. Hansen, CEO OmniCar Holding AB E-mail: cth@omnicar.dk

Interim report 3 2019 Invent Medic Sweden AB

CEO Karin Bryder summarizes the quarterDuring the third quarter of 2019, we have spent alot of time on preparing the launches of efemia inthe UK and Germany which are taking place nowin the fourth quarter. Among other things, we havedelivered the first product orders. At the same time,we continue our marketing of efemia in Sweden,where several regions in the healthcare sector finallyinitiated relevant procurement processes in whichwe participate with efemia. During the quarter, wealso participated in the International ContinenceSociety’s (ICS) annual meeting in Gothenburg.There was a great

Transcendent Group launches a new service within RegTech

Transcendent Group launches the first version of an add-on module for its digital service Regulatory Framework Application (RFA) – RFA Monitor, a tool that facilitates for the user to stay up-to-date on new and updated regulations.RFA is a digital service where the internal regulatory framework can be developed, decided on, administrated and updated. ”In practice, RFA means that our customers can focus on application and implementation, instead of spending time on administration and updates. Our new add-on module RFA is an easy tool for keeping up with all regulatory changes coming from

Summons to bondholders’ meetings

Bonheur ASA has called for bondholders' meetings for the bond issues "BON06" (ISIN NO0010714538), "BON07" (ISIN NO0010793565) and "BON08" (ISIN NO0010809577) to harmonize the equity ratio definition with the newly issued BON 09 (ISIN NO0010861313). The bondholders’ meetings will be held on 14 November 2019 at 13:00. Please see the attachment for further information. For questions, please contact: Bonheur ASA Øyvind B. Kristiansen, Fred. Olsen & Co., +47 90 01 05 29 or oyvind.kristiansen@fredolsen.com Haakon Magne Ore, Fred. Olsen & Co., +47 92 02 75 10 or hmore@fredolsen.com

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover ”) has changed as a result of conversions of in total 5,065 class A shares into class B shares carried out in October following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 135,735,195 shares in Medicover, of which 78,796,431 are class A shares, together carrying 78,796,431 votes, 54,538,764 are class B shares, together carrying 5,453,876.4 votes and 2,400,000 are class C shares,

Managers’ transactions

Nordea Bank Abp – Stock exchange release – Managers’ transactions Transaction notification under Article 19 of the EU Market Abuse Regulation Person subject to the notification requirementName: Steen, BirgerPosition: Member of the Board of DirectorsIssuer: Nordea Bank AbpLEI: 529900ODI3047E2LIV03 Notification type: Initial NotificationReference number: 529900ODI3047E2LIV03_20191029152403_2 Transaction date: 2019-10-29Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)Instrument type: SHAREISIN: FI4000297767Nature of the transaction: Acquisition    Transaction details

Invitation to Alfa Laval’s Capital Markets Day, December 5

Alfa Laval invites analysts, professional investors and media to its Capital Markets Day, which will be held on December 5 at Malmö Arena Hotel, Hyllie Boulevard 12, Malmö, Sweden. It will start at 11:00 CET and end at approximately 16:00 CET. For those of you arriving to Copenhagen Airport, we will offer a shuttle from the airport to Malmö Arena Hotel, just a 15 minutes ride to the other side of the bridge between Denmark and Sweden. The first part will include presentations by Jan Allde, CFO and Mikael Tydén, Head of Operations. This contains an update on the larger investment programs

Nomination Committee for Duni’s AGM 2020

Pursuant to a resolution adopted at Duni’s Annual General Meeting in 2019, a Nomination Committee has been appointed prior to the Annual General Meeting in 2020. Duni hereby announces the composition of the Nomination Committee.The following persons will serve on the Nomination Committee, which is charged with presenting proposals to the Annual General Meeting in 2020 regarding the composition of Duni’s Board of Directors, etc.: Mr Johan Andersson, Mellby Gård Investerings ABMr John Strömgren, Carnegie fonderMr Bernard R. Horn, Jr., Polaris Capital Management, LLCMr Magnus Yngen,

Metsä Wood awards Estonian start-up Team 99 for an eco-friendly modular design

Metsä Wood, a Finnish engineered wood product company, has awarded the Estonian start-up Team 99 for its innovative design of a module that can be used to construct buildings of different sizes and shapes, at the same time reducing their overall carbon footprint. The module has been completely designed using Metsä Wood’s Kerto LVL (laminated veneer lumber) products – making the design fast, light and green. The awarded design was one of the outcomes of the wood hackathon Future of Wood, organised by the Academy of Art and Garage 48 in Tallinn. The event, which attracted about 100

Capital increase in TORM due to exercise of Restricted Share Units

TORM plc (“TORM”) will increase its share capital by 42,533 A-shares (corresponding to a nominal value of USD 425.33) as a result of the exercise of a corresponding number of Restricted Share Units. The capital increase will be carried out without any pre-emption rights for existing shareholders or others. The new shares have been subscribed for in cash at DKK 53.7 per A-share with a nominal value of USD 0.01 each. The new shares are ordinary shares without any special rights and are negotiable instruments. The new shares will be freely transferable on Nasdaq in Copenhagen, but

Telephone conference Actic’s interim report Q3 2019

Actic’s interim report for the first nine months 2019 will be published on Wednesday 6 November at 07:45 am CET. A telephone conference will be held at 10:00 am CET on the same day, where CEO Anders Carlbark and CFO Jörgen Fritz comments on the report. The telephone number is +46 8 229090 and the code 426565#. Before the conference a presentation will be published on: www.acticgroup.com For further information, please contact: Jörgen Fritz, CFO, jorgen.fritz@actic.se, +46 73 663 54 74

Invitation to a teleconference and audiocast in connection with Arise´s Q3-report for 2019

Arise’s Q3-report for 2019 will be released on Friday 8 November, 2019 at around 08.00 CET. At 11.00 on the same day a teleconference will be held, hosted by Daniel Johansson, CEO and Linus Hägg, CFO, who will present the report to the stock market and media. After the presentation those attending will be invited to ask questions. The dial in number for the conference call is: Sweden:                                           +46 8 566 426 95 UK:                                                   +44 33 330 092 72 During the teleconference a presentation will be held. To

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In October 2019, at the request of shareholders, 200 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 158,448,443.9. The total number of registered shares in the company amounts to 576,343,778 shares

Karnov’s Nomination Committee appointed

Karnov Group AB (Nasdaq: KAR), the leading Nordic legal-information provider, has appointed its Nomination Committee for the Annual General Meeting 2020 in accordance with the Instruction for the Nomination Committee.The Nomination Committee consists of:  • Sacha Oshry, Director, Rothschild & Co, Five Arrows Principal Investments, U.K. • Christian Petersen, Operating Executive, Vind LV AS, Norway • Thomas Ehlin, Corporate Governance, Fourth National Pension Fund, Sweden and • Magnus Mandersson, Chairman of the Board of Directors, Karnov Group AB. Mr. Sacha Oshry is the

Invitation to Eltel’s third quarter 2019 interim report presentation

Eltel will publish its interim report for the third quarter 2019 on Thursday 7 November 2019 at approximately 08.00 am CET. Eltel’s CEO Casimir Lindholm and CFO Petter Traaholt will host a presentation via audiocast in English starting at 10.00 am CET.The presentation will be audiocasted live on www.eltelgroup.com. For those who would like to participate in the telephone conference in connection with the presentation, the telephone numbers are: ·  SE: +46 8 5199 9383 ·  FI: +358 9 8171 0522 ·  UK: +44 33 3300 9270 Please, call well in advance to register. After the

Karolinska University Hospital participates as the only Swedish hospital in a global clinical CAR T-cell study for treatment of aggressive lymphoma. First adult patient has been treated at Karolinska

On August 27, 2019, the first patient in Sweden, and the third in Europe, was treated with genetically modified CAR-T cells as part of the TRANSFORM study at Karolinska University Hospital Huddinge at the Department of Cell Therapy and Allogeneic Stem Cell Transplant (CAST). The treatment is conducted within the framework of a randomized clinical trial that offers either standard autologous stem cell transplantation therapy or experimental treatment with CD19-CAR-Tcells (JCAR17).The patient included in the study has been diagnosed with a relapse of an aggressive form of lymphoma included in

Lack of alignment between business goals and quality ambitions impedes Agile and DevOps adoption

The World Quality Report also reveals skills and security challenges as major hindrances for organizations to uplift their testing and IT environment.Paris, October 31, 2019 – The World Quality Report  2019-20 (WQR), released today by Capgemini and Sogeti, part of the Capgemini Group, and published in conjunction with Micro Focus , shows alignment with business priorities and customer

Tikkurila Color of the Year 2020: When life gives you lemons, make lemonade

Tikkurila's color of the year is H300 Lemonade, which represents positivity and optimism. The color and color collection of the year invites you to look on the bright side of life. Tikkurila’s H300 Lemonade is a continuation of the yellow trend that has been seen in fashion and decor. At the same time, it is bright and soft, energizing and sophisticated – a delightful shade to replace everyday grey and beige. H300 Lemonade is a breath of fresh air and reminds us of the power of positivity. There is always a flash of light somewhere, there is always the opportunity for change – both at

Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA

Navamedic ASA, 31 October 2019: The shares in Navamedic ASA (the "Company" or "NAVA") will today on Thursday 31 October 2019 for the last day trade inclusive of rights to consideration shares in Observe Medical ASA ("Observe Medical") to be distributed in connection with the demerger of NAVA. The demerger, whereby inter alia NAVA's Medtech division is demerged from NAVA and merged into Observe Medical against distribution of the shares in Observe Medical to the existing shareholders of NAVA, was approved by the general meetings of the Company and Observe Medical on 5 August 2019. The

Navamedic ASA shares: Last day of trading inclusive of rights to consideration shares in Observe Medical ASA

Navamedic ASA, 31 October 2019: The shares in Navamedic ASA ("NAVA") will today on Thursday 31 October 2019 for the last day trade inclusive of rights to consideration shares in Observe Medical ASA ("Observe Medical") to be distributed in connection with the demerger of NAVA. The demerger, whereby inter alia NAVA's Medtech division is demerged from NAVA and merged into Observe Medical against distribution of the shares in Observe Medical to the existing shareholders of NAVA, was approved by the general meetings of NAVA and Observe Medical on 5 August 2019. The creditor notice period for

There are no items matching the current filter
There are no more items matching the current filter
Back to top